Craig A Collard Heron Therapeutics, Inc. (HRTX) insider trading activity

Craig A Collard is Chief Executive Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 523,124 shares of HRTX, which is worth approximately $575,436. The most recent transaction as insider was on Oct 31, 2025, when has been sold 34,789 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 523K

10.24% 3M change

80.15% 12M change

Total Value Held $575,436

Craig A Collard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2025	BUY Exercise of conversion of derivative security	-	34,789 Added 6.24%	523,124 Common Stock
Oct 19 2025	BUY Exercise of conversion of derivative security	-	13,797 Added 2.75%	488,335 Common Stock
Jul 31 2025	BUY Exercise of conversion of derivative security	-	34,789 Added 6.83%	474,538 Common Stock
Jul 19 2025	BUY Exercise of conversion of derivative security	-	13,797 Added 3.04%	439,749 Common Stock
Apr 30 2025	BUY Exercise of conversion of derivative security	-	34,789 Added 7.55%	425,952 Common Stock
Apr 19 2025	BUY Exercise of conversion of derivative security	-	13,796 Added 3.41%	391,163 Common Stock
Apr 03 2025	BUY Exercise of conversion of derivative security	-	62,500 Added 14.21%	377,367 Common Stock

Jan 19 2025	BUY Exercise of conversion of derivative security	-	13,797 Added 4.2%	314,867 Common Stock
Oct 19 2024	BUY Exercise of conversion of derivative security	-	13,797 Added 4.54%	290,387 Common Stock
Jul 19 2024	BUY Exercise of conversion of derivative security	-	13,797 Added 4.75%	276,590 Common Stock
Apr 19 2024	BUY Exercise of conversion of derivative security	-	13,797 Added 4.99%	262,793 Common Stock
Apr 03 2024	BUY Exercise of conversion of derivative security	-	62,500 Added 20.06%	248,996 Common Stock
Nov 16 2023	BUY Open market or private purchase	$138,000 $0.92 p/Share	150,000 Added 44.58%	186,496 Common Stock
Aug 22 2023	SELL Payment of exercise price or tax liability	$1,141 $1.65 p/Share	692 Reduced 1.86%	36,496 Common Stock
May 22 2023	SELL Payment of exercise price or tax liability	$1,001 $1.45 p/Share	691 Reduced 1.82%	37,188 Common Stock

Also insider at

SRRA

Sierra Oncology, Inc. Healthcare

Director

OPNT

OPIANT PHARMACEUTICALS, INC. Healthcare

Director

TRSSF

TerrAscend Corp. Healthcare

CAC

Craig A Collard

Chief Executive Officer

Mississauga, A6

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to HERON THERAPEUTICS, INC.

Track Activities on HRTX

Account